As a component of the benzamidoxime prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: mARC2; Mitochondrial amidoxime reducing component 2; moco sulfurase C-terminal domain-containing protein 2; MOCO sulphurase C-terminal domain containing 2; Molybdenum cofactor sulfurase C-terminal domain-containing protein 2; MOSC domain-containing protein 2; MOSC domain-containing protein 2, mitochondrial; MOSC2; RP11 270A6.1
Gene Aliases: 2810484M10Rik; mARC1; MARC2; Mg87; MOSC2